Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin as Add-on Therapy in Generalized Epilepsy
NCT03590197Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Aug 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in generalized epilepsy, sponsored by AIIMS New Delhi. Started Aug 2018; status: completed.
02
Drugs
melatonin
03
Conditions
generalized epilepsy
Beyond the preview
Go deeper on NCT03590197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03590197.